FSDDF - FSD Pharma Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1060
-0.0008 (-0.75%)
At close: 3:42PM EDT
Stock chart is not supported by your current browser
Previous Close0.1068
Open0.1080
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1010 - 0.1080
52 Week Range0.0870 - 0.8750
Volume216,441
Avg. Volume332,659
Market Cap142.206M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0010
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNW Group12 hours ago

    High Tide Announces Research Analyst Coverage by Canaccord Genuity

    High Tide Announces Research Analyst Coverage by Canaccord Genuity

  • CNW Group8 days ago

    High Tide Announces Canna Cabana Selling Cannabis at 2 More Alberta Locations

    High Tide Announces Canna Cabana Selling Cannabis at 2 More Alberta Locations

  • Benzinga15 days ago

    FSD Pharma Closes Prismic Pharma Acquisition: 'A Paradigm Shift In The Overall Outlook Of The Company'

    FSD Pharma Inc (OTC: FSDDF ) announced this week it closed a deal to acquire Prismic Pharmaceuticals, a U.S.-based specialty pharmaceutical company dedicated to addressing the opioid crisis. Through the ...

  • CNW Group15 days ago

    High Tide Announces Canna Cabana Now Selling Cannabis in Grande Prairie with 10 More Alberta Stores to Follow Shortly

    High Tide Announces Canna Cabana Now Selling Cannabis in Grande Prairie with 10 More Alberta Stores to Follow Shortly

  • Business Wire16 days ago

    FSD Pharma Closes Deal to Acquire Prismic Pharmaceuticals

    FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) (“FSD Pharma” or the “Company”) and Prismic Pharmaceuticals Inc. (“Prismic”), a US-based specialty R&D pharmaceutical company (the “Parties”), announced today that, on June 28, 2019, they finalized the acquisition by FSD Pharma of all of the issued and outstanding securities of Prismic (the "Transaction"). Pursuant to the terms of a previously-announced securities exchange Agreement, FSD Pharma has acquired all outstanding common and preferred shares of Prismic for an aggregate purchase price of approximately US$17.5 million (CAD$23.4 million based on an exchange rate of US$1 to CAD$1.3349), satisfied by the issuance of approximately 102.7 million Class B subordinate voting shares in the capital of FSD Pharma (each, an “FSD Share”) at a deemed price of CAD$0.2275 (US$0.1704) per FSD Share.

  • CNW Group21 days ago

    High Tide Reports Financial Results for Second Quarter 2019 Featuring a 325% Increase in Revenue over the Same Period of the Previous Year

    High Tide Reports Financial Results for Second Quarter 2019 Featuring a 325% Increase in Revenue over the Same Period of the Previous Year

  • CNW Group22 days ago

    High Tide Upgrades Grasscity to Magento 2 E-Commerce Platform

    As part of upgrading to the M2 platform the Company also improved Grasscity's warehouse management system, which is designed to reduce processing times and error rates, thereby increase shipments for faster delivery times to customers around the world. "We are excited to reap the benefits of this significant investment in Grasscity as the most searchable online retailer of smoking accessories.

  • Business Wire24 days ago

    FSD Pharma Receives Full “Sale for Medical Purposes” Cannabis License from Health Canada

    FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) (“FSD” or the “Company”), announced today that its wholly-owned subsidiary FV Pharma Inc. (“FV Pharma”) has received its Full Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Canada). The latest amendment to the license, originally granted on April 18, 2019, allows the FSD facility in Cobourg, Ontario to supply and sell cannabis products, including dried and fresh cannabis to the medicinal use marketplace.

  • FSD Pharma Receives Full "Sale for Medical Purposes" Cannabis License from Health Canada
    CNW Group24 days ago

    FSD Pharma Receives Full "Sale for Medical Purposes" Cannabis License from Health Canada

    TORONTO , June 24, 2019 /CNW/ - FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), announced today that its wholly-owned subsidiary FV Pharma Inc. ("FV Pharma") has received its Full Sale for Medical Purposes license to sell cannabis under the Cannabis Act ( Canada ). The latest amendment to the license, originally granted on April 18, 2019 , allows the FSD facility in Cobourg, Ontario to supply and sell cannabis products, including dried and fresh cannabis to the medicinal use marketplace. FV Pharma can now begin delivering cannabis to patients who hold prescriptions from authorized healthcare providers.

  • CNW Grouplast month

    High Tide Closes Final Tranche of Oversubscribed Convertible Debenture Offering

    CALGARY , June 17, 2019 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (HITI.CN) (HITIF) (2LY.F), an Alberta -based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today announced that it has closed the final tranche (the "Final Tranche") of the sale of unsecured convertible debentures (the "Debentures") of the Company under the non-brokered private placement (the "Offering") previously announced on April 10, 2019 . Gross proceeds from the Final Tranche were $3,200,000 and included a subsequent investment of $1,000,000 from Aurora Cannabis Inc. (ACB) (ACB.TO), one of the Company's key industry partners.

  • Newsfilelast month

    FSD Pharma Continues to Add Expert Advisors Amid Buildout of Massive Facility -- CFN Media

    Seattle, Washington--(Newsfile Corp. - June 14, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF). The company has been focused on building out its board of directors and advisory board since becoming a full Canadian licensed producer earlier this year. After receiving its cultivation license in 2017, the company ...

  • CNW Grouplast month

    High Tide Announces AGCO Authorization to Open Canna Cabana Toronto Retail Cannabis Store

    High Tide Announces AGCO Authorization to Open Canna Cabana Toronto Retail Cannabis Store

  • Business Wirelast month

    FSD Pharma Adds Biotech/LifeSciences Industry veteran James A. Datin and Robert J. Ciaruffoli, Former Chairman & CEO of Parente Beard/Baker Tilly to Board of Directors

    FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), today announced the appointment of James A. Datin and Robert J. Ciaruffoli, CPA to the Company’s Board of Directors. “It is an honor to welcome Jim Datin and Bob Ciaruffoli to the FSD Pharma Board of Directors,” said Dr. Raza Bokhari, Executive Co-Chairman and CEO. “The experience and expertise they both bring as c-level entrepreneurial executives, leaders and board members of impressive organizations will add tremendous value to FSD.

  • FSD Pharma Adds Biotech/LifeSciences Industry veteran James A. Datin and Robert J. Ciaruffoli, Former Chairman & CEO of Parente Beard/Baker Tilly to Board of Directors
    CNW Grouplast month

    FSD Pharma Adds Biotech/LifeSciences Industry veteran James A. Datin and Robert J. Ciaruffoli, Former Chairman & CEO of Parente Beard/Baker Tilly to Board of Directors

    TORONTO , June 12, 2019 /CNW/ - FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), today announced the appointment of James A. Datin and Robert J. Ciaruffoli, CPA to the Company's Board of Directors. "It is an honor to welcome Jim Datin and Bob Ciaruffoli to the FSD Pharma Board of Directors," said Dr. Raza Bokhari, Executive Co-Chairman and CEO. "The experience and expertise they both bring as c-level entrepreneurial executives, leaders and board members of impressive organizations will add tremendous value to FSD.

  • Business Wirelast month

    FSD Pharma Adds Two More Prominent Cannabis Researchers to Scientific Advisory Board

    FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) (“FSD” or the “Company”), is pleased to announce the addition of two distinguished cannabis researchers to the company’s Scientific Advisory Board (“SAB”). “It is with great pride that we welcome Dr. Ziva Cooper and Dr. Mallory Loflin to our Scientific Advisory Board. The board, which also includes Dr. Daniel Piomelli and Dr. Ryan Vandrey, is shaping into a very robust body of scientists and researchers under the leadership of my good friend Dr. Pollack and I commend him for his leadership.

  • FSD Pharma Adds Two More Prominent Cannabis Researchers to Scientific Advisory Board
    CNW Grouplast month

    FSD Pharma Adds Two More Prominent Cannabis Researchers to Scientific Advisory Board

    TORONTO , June 6, 2019 /CNW/ - FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), is pleased to announce the addition of two distinguished cannabis researchers to the company's Scientific Advisory Board ("SAB"). "It is with great pride that we welcome Dr. Ziva Cooper and Dr. Mallory Loflin to our Scientific Advisory Board.

  • CNW Grouplast month

    High Tide Announces Smoker's Corner Store in the Royal Chapelle Area of Edmonton

    CALGARY , June 4, 2019 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (HITI.CN) (HITIF) (2LY.F), an Alberta -based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today announced that it has opened a new Smoker's Corner retail store in the Royal Chapelle Area of Edmonton , specifically located at 3142 141 Street SW in Edmonton, Alberta (the "Royal Chapelle Store"). Similar to High Tide's other Smoker's Corner locations, the Royal Chapelle Store will be supplied from the Company's vast catalogue of more than 4,300 SKUs of smoking accessories and cannabis lifestyle products, including the full range of proprietary and licensed goods offered by its wholesale segment.

  • Newsfilelast month

    FSD Pharma Brings in World-Renowned Experts to Build Bioscience Division -- CFN Media

    Seattle, Washington--(Newsfile Corp. - June 4, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF). The company may be known for having one of the largest cultivation footprints in the world with nearly 70 acres and four million square feet, but it's equally focused on advancing the science behind ...

  • Dr. Raza Bokhari, FSD Pharma Executive Co-Chairman and CEO to Participate in Biotech-Focused Panel at the 2019 BIO International Convention
    CNW Grouplast month

    Dr. Raza Bokhari, FSD Pharma Executive Co-Chairman and CEO to Participate in Biotech-Focused Panel at the 2019 BIO International Convention

    Dr. Raza Bokhari, FSD Pharma Executive Co-Chairman and CEO to Participate in Biotech-Focused Panel at the 2019 BIO International Convention

  • Business Wirelast month

    FSD Pharma Names Raza Bokhari, M.D. as Permanent CEO

    The Board of Directors of FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), unanimously voted Raza Bokhari, M.D., Executive Co-Chairman of the Board, as permanent Chief Executive Officer. Dr. Bokhari has served as interim CEO of the Company since February.

  • CNW Group2 months ago

    High Tide Celebrates Lifting of Alberta Retail Licencing Moratorium with 9 More Stores Ready to Sell Cannabis Products

    CALGARY , May 31, 2019 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (HITI.CN) (HITIF) (2LY.F), an Alberta -based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today is celebrating the announcement by Alberta Gaming, Liquor and Cannabis ("AGLC") that it has lifted the moratorium on issuing retail cannabis licences and accepting new licence applications. The announcement provides certainty and clarity for the licencing of nine approved Canna Cabana locations currently selling accessories, as well as for the next 23 locations in various stages of development, in addition to the four Canna Cabana locations currently selling cannabis in Alberta .

  • FSD Pharma Congratulates High Tide on the Resumption of Retail Cannabis Licensing by AGLC in Alberta
    CNW Group2 months ago

    FSD Pharma Congratulates High Tide on the Resumption of Retail Cannabis Licensing by AGLC in Alberta

    TORONTO , May 31, 2019 /CNW/ - FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company") would like to congratulate High Tide Inc. (CSE:HITI) (HITIF) (2LY.F) ("High Tide") on the recent announcement from Alberta Gaming, Liquor and Cannabis lifting the moratorium on issuing cannabis licenses and accepting license applications. The announcement is an encouraging sign of steadily improving cannabis supply levels in Alberta and is a positive step for companies like High Tide that have numerous stores ready and waiting to retail cannabis products. As a strategic investor in High Tide, FSD Pharma is pleased to see changes that will support the continued growth and success of the cannabis industry as well as the companies in which it is invested.